BMY vs. KO
BMY (Bristol-Myers Squibb Company) and KO (The Coca-Cola Company) are both stocks. BMY operates in Drug Manufacturers - General (Healthcare), while KO operates in Beverages - Non-Alcoholic (Consumer Defensive). Over the past 10 years, BMY returned 1.11%/yr vs 9.61%/yr for KO. At a 0.36 correlation, their price movements are largely independent.
Performance
BMY vs. KO - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, BMY achieves a 10.98% return, which is significantly lower than KO's 19.80% return. Over the past 10 years, BMY has underperformed KO with an annualized return of 1.11%, while KO has yielded a comparatively higher 9.61% annualized return.
BMY
- 1D
- 1.81%
- 1M
- 2.41%
- YTD
- 10.98%
- 6M
- 10.63%
- 1Y
- 32.66%
- 3Y*
- 1.71%
- 5Y*
- 1.39%
- 10Y*
- 1.11%
KO
- 1D
- 0.02%
- 1M
- 5.28%
- YTD
- 19.80%
- 6M
- 19.38%
- 1Y
- 20.85%
- 3Y*
- 14.45%
- 5Y*
- 12.11%
- 10Y*
- 9.61%
BMY vs. KO - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
BMY Bristol-Myers Squibb Company | 10.98% | 0.11% | 15.81% | -26.14% | 18.98% | 2.88% | 0.41% | 27.74% | -12.90% | 7.71% |
KO The Coca-Cola Company | 19.80% | 15.60% | 8.88% | -4.43% | 10.61% | 11.37% | 2.47% | 20.60% | 6.77% | 14.38% |
Correlation
The correlation between BMY and KO is 0.29, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.29 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.32 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.34 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.31 |
Correlation (All Time) Calculated using the full available price history since Jun 1, 1972 | 0.36 |
Fundamentals
BMY:
$119.67B
KO:
$356.55B
BMY:
$3.56
KO:
$3.18
BMY:
16.43
KO:
26.02
BMY:
0.94
KO:
3.14
BMY:
2.47
KO:
7.23
BMY:
5.96
KO:
10.60
BMY:
$48.48B
KO:
$49.28B
BMY:
$33.33B
KO:
$30.43B
BMY:
$13.34B
KO:
$18.35B
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
BMY vs. KO — Risk / Return Rank
BMY
KO
BMY vs. KO - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Bristol-Myers Squibb Company (BMY) and The Coca-Cola Company (KO). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| BMY | KO | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -0.04 | ||
| Sortino ratioReturn per unit of downside risk | -0.14 | ||
| Omega ratioGain probability vs. loss probability | 1.22 | 1.22 | 0.00 |
| Calmar ratioReturn relative to maximum drawdown | 2.62 | 2.66 | -0.04 |
| Martin ratioReturn relative to average drawdown | 5.83 | 5.27 | +0.55 |
Loading charts...
Drawdowns
BMY vs. KO - Drawdown Comparison
The maximum BMY drawdown since its inception was -72.03%, which is greater than KO's maximum drawdown of -68.23%. Use the drawdown chart below to compare losses from any high point for BMY and KO.
Loading charts...
Drawdown Indicators
| BMY | KO | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -72.03% | -68.23% | -3.80% |
Max Drawdown (1Y)Largest decline over 1 year | -12.53% | -7.87% | -4.66% |
Max Drawdown (3Y)Largest decline over 3 years | -36.02% | -16.26% | -19.76% |
Max Drawdown (5Y)Largest decline over 5 years | -47.67% | -17.27% | -30.40% |
Max Drawdown (10Y)Largest decline over 10 years | -47.67% | -36.99% | -10.68% |
Current DrawdownCurrent decline from peak | -15.73% | -0.49% | -15.24% |
Average DrawdownAverage peak-to-trough decline | -22.37% | -16.08% | -6.29% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 5.62% | 3.96% | +1.66% |
Volatility
BMY vs. KO - Volatility Comparison
Bristol-Myers Squibb Company (BMY) has a higher volatility of 9.25% compared to The Coca-Cola Company (KO) at 7.01%. This indicates that BMY's price experiences larger fluctuations and is considered to be riskier than KO based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| BMY | KO | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 9.25% | 7.01% | +2.24% |
Volatility (6M)Calculated over the trailing 6-month period | 18.43% | 12.98% | +5.45% |
Volatility (1Y)Calculated over the trailing 1-year period | 27.33% | 16.87% | +10.46% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 24.15% | 16.21% | +7.94% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 25.32% | 18.24% | +7.08% |
Dividends
BMY vs. KO - Dividend Comparison
BMY's dividend yield for the trailing twelve months is around 4.27%, more than KO's 2.52% yield.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
BMY Bristol-Myers Squibb Company | 4.27% | 4.60% | 4.24% | 4.44% | 3.00% | 2.36% | 3.69% | 2.55% | 3.08% | 2.55% | 1.95% | 2.17% |
KO The Coca-Cola Company | 2.52% | 2.92% | 3.12% | 3.12% | 2.77% | 2.84% | 2.99% | 2.89% | 3.29% | 3.23% | 3.38% | 3.07% |
Financials
BMY vs. KO - Financials Comparison
This section allows you to compare key financial metrics between Bristol-Myers Squibb Company and The Coca-Cola Company. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
BMY vs. KO - Profitability Comparison
BMY - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Bristol-Myers Squibb Company reported a gross profit of 8.07B and revenue of 11.49B. Therefore, the gross margin over that period was 70.2%.
KO - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, The Coca-Cola Company reported a gross profit of 7.85B and revenue of 12.47B. Therefore, the gross margin over that period was 63.0%.
BMY - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Bristol-Myers Squibb Company reported an operating income of 3.27B and revenue of 11.49B, resulting in an operating margin of 28.5%.
KO - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, The Coca-Cola Company reported an operating income of 4.36B and revenue of 12.47B, resulting in an operating margin of 35.0%.
BMY - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Bristol-Myers Squibb Company reported a net income of 2.68B and revenue of 11.49B, resulting in a net margin of 23.3%.
KO - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, The Coca-Cola Company reported a net income of 3.92B and revenue of 12.47B, resulting in a net margin of 31.5%.
Frequently Asked Questions
BMY and KO have a correlation of 0.29, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
BMY has higher volatility (9.25%) compared to KO (7.01%). In terms of maximum drawdown, BMY dropped -72.03% vs KO's -68.23%.
KO currently has the higher Sharpe Ratio (1.24 vs 1.20), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for BMY and KO
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer